APRE logo

Aprea Therapeutics, Inc. (APRE)

Profile

Full Name

Aprea Therapeutics, Inc.

Ticker

NASDAQ: APRE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 3, 2019

Indexes

Not included

Website

https://aprea.com

Employees

8

Key Details

Price

$1.69(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.50M(+157.65% YoY)

Annual EPS

-$2.35(+40.51% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.69
    APRE price is $1.69

    30-Day Relative Volume

    0.31
    APRE 30-day relative volume is 0.31

    Price Performance

    Price Most recent change

    0%
    APRE price has remained unchanged on Aug 15, 2025

    Price YTD change

    -48.63%
    APRE price is down -48.63% since January 1st

    Price 1-year change

    -55.53%
    APRE price is down -55.53% year-on-year

    Price 3-year change

    -90.52%
    APRE price is down -90.52% over the past 3 years

    Price Range

    Price All-time high

    $1062.20
    APRE price is currently -99.84% below its historical high of $1062.20

    Price 3-year low

    $0.47
    APRE price is currently +256.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.84M
    APRE market capitalization is $9.84 million

    Market cap 3-year change

    -52.79%
    APRE market capitalization is down -52.79% over the past 3 years

    Market cap All-time high

    $1.04B
    APRE market capitalization is currently -99.05% below its historical high of $1.04 billion

    Market cap sector rank

    16.17%
    APRE market capitalization is higher than 16.17% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +7.24%
    APRE shares outstanding is up +7.24% year-on-year

    Shares Outstanding 3-Year Change

    +397.85%
    APRE shares outstanding is up +397.85% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.62
    APRE beta is 0.62

    200-day SMA

    $2.52
    APRE price is currently -32.86% below its 200-day simple moving average

    50-day SMA

    $1.75
    APRE price is currently -3.58% below its 50-day simple moving average

    RSI

    46.96
    APRE 14-day relative strength index is 46.96

    Volume

    0.31
    APRE 30-day relative volume is 0.31

    ATR

    $0.12
    APRE average true range is $0.12

    10-day Historical Volatility

    56.85%
    APRE 10-day historical volatility is 56.85%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.50M
    APRE annual revenue is $1.50 million

    Revenue Analysts estimate

    $281.00K
    APRE annual revenue is currently +434.73% higher than the consensus analysts' forecast

    Revenue 1-year change

    +157.65%
    APRE annual revenue is up +157.65% year-on-year

    Revenue Sector rank

    38.14%
    APRE annual revenue is higher than 38.14% of companies in Healthcare sector

    EPS

    EPS

    -$2.35
    APRE annual earnings per share is -$2.35

    EPS Analysts estimate

    -$0.67
    APRE annual earnings per share is currently +250.75% higher than the consensus analysts' forecast

    EPS 1-year change

    +40.51%
    APRE annual earnings per share is up +40.51% year-on-year

    EPS Sector rank

    34.52%
    APRE annual earnings per share is higher than 34.52% of companies in Healthcare sector

    Profit

    Gross profit

    $1.48M
    APRE annual gross profit is $1.48 million

    Gross margin

    98.52%
    APRE annual gross profit margin is 98.52%

    Operating profit

    -$14.32M
    APRE annual operating income is -$14.32 million

    Operating margin

    -952.99%
    APRE annual operating profit margin is -952.99%

    Net income

    -$12.96M
    APRE annual net profit is -$12.96 million

    Net margin

    -862.42%
    APRE annual net profit margin is -862.42%

    Expenses

    Total expenses

    $14.32M
    APRE annual total expenses is $14.32 million

    Operating expenses

    $14.32M
    APRE annual total operating expenses is $14.32 million

    Cost of goods sold

    $22.30K
    APRE annual cost of goods sold is $22.30 thousand

    Selling, general & administrative expenses

    $6.46M
    APRE annual SGA is $6.46 million

    Depreciation and amortization

    $22.30K
    APRE annual depreciation & amortization is $22.30 thousand

    Interest expense

    $0.00
    APRE annual interest expense is $0.00

    Income tax

    $0.00
    APRE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$14.32M
    APRE annual earnings before interest & taxes is -$14.32 million

    EBITDA

    -$14.30M
    APRE annual EBITDA is -$14.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $23.98M
    APRE annual total assets is $23.98 million

    Non current assets

    $403.40K
    APRE annual long term assets is $403.40 thousand

    Current assets

    $23.58M
    APRE annual total current assets is $23.58 million

    Cash and cash equivalents

    $22.85M
    APRE annual cash & cash equivalents is $22.85 million

    Accounts receivable

    -
    APRE annual accounts receivable value is unknown

    Inventory

    $0.00
    APRE annual inventory is $0.00

    Liabilities

    Total liabilities

    $3.36M
    APRE annual total liabilities is $3.36 million

    Long term liabilities

    $1.31M
    APRE annual total long term liabilities is $1.31 million

    Current liabilities

    $3.36M
    APRE annual total current liabilities is $3.36 million

    Accounts payable

    $1.35M
    APRE annual accounts payable is $1.35 million

    Debt

    Total debt

    $0.00
    APRE annual total debt is $0.00

    Total debt 1-year change

    0%
    APRE annual total debt has remained unchanged year-on-year

    Long term debt

    -
    APRE annual long term debt value is unknown

    Short term debt

    -
    APRE annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $20.62M
    APRE annual stockholders equity is $20.62 million

    Book value

    $19.31M
    APRE annual book value is $19.31 million

    Retained earnings

    -$321.04M
    APRE annual retained earnings is -$321.04 million

    Working capital

    $20.22M
    APRE annual working capital is $20.22 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$13.56M
    APRE annual cash flow from operations is -$13.56 million

    Cash from operations 1-year change

    -11.32%
    APRE annual cash flow from operations is down -11.32% year-on-year

    Cash from investing

    -$15.50K
    APRE annual cash flow from investing activities is -$15.50 thousand

    Cash from investing 1-year change

    +83.35%
    APRE annual cash flow from investing activities is up +83.35% year-on-year

    Cash from financing

    $14.82M
    APRE annual cash flow from financing activities is $14.82 million

    Cash from financing 1-year change

    +188.36%
    APRE annual cash flow from financing activities is up +188.36% year-on-year

    CAPEX

    CAPEX

    $15.50K
    APRE annual capital expenditures is $15.50 thousand

    CAPEX 1-year change

    -83.35%
    APRE annual capital expenditures is down -83.35% year-on-year

    Free Cash Flow

    Free cash flow

    -$13.57M
    APRE annual free cash flow is -$13.57 million

    Free cash flow 1-year change

    -10.61%
    APRE annual free cash flow is down -10.61% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    98.52%
    APRE annual gross profit margin is 98.52%

    Operating margin

    -952.99%
    APRE annual operating profit margin is -952.99%

    Net margin

    -862.42%
    APRE annual net profit margin is -862.42%

    ROA & ROE

    ROA

    -55.58%
    APRE annual return on assets is -55.58%

    ROE

    -66.65%
    APRE annual return on equity is -66.65%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    APRE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    APRE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.73
    APRE price to book ratio is 0.73

    PB ratio Sector rank

    31.09%
    APRE price to book ratio is higher than 31.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    11.71
    APRE price to sales ratio is 11.71

    PS ratio Sector rank

    75.83%
    APRE price to sales ratio is higher than 75.83% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$6.69M
    APRE enterprise value is -$6.69 million

    Enterprise value Sector rank

    8.6%
    APRE enterprise value is higher than 8.6% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.45
    APRE EV/EBITDA is 0.45

    EV/EBITDA Sector rank

    69.71%
    APRE EV/EBITDA is higher than 69.71% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.01
    APRE annual current ratio is 7.01

    Quick ratio

    7.01
    APRE annual quick ratio is 7.01

    Leverage

    Debt to equity

    0.00
    APRE annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    APRE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    APRE piotroski f-score value is unknown

    Altman Z-Score

    -17.88
    APRE altman z-score is -17.88

    Analyst ratings

    Recent major analysts updates

    Jan 15, 25 HC Wainwright & Co.
    Buy
    Dec 17, 24 HC Wainwright & Co.
    Buy
    Nov 18, 24 HC Wainwright & Co.
    Buy
    Oct 24, 24 HC Wainwright & Co.
    Buy
    Aug 13, 24 Wedbush
    Outperform
    Aug 12, 24 HC Wainwright & Co.
    Buy
    Jun 24, 24 HC Wainwright & Co.
    Buy
    Jun 17, 24 HC Wainwright & Co.
    Buy
    May 14, 24 HC Wainwright & Co.
    Buy
    Mar 27, 24 Wedbush
    Outperform

    Institutional Ownership

    Screeners with APRE included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Aprea Therapeutics, Inc.?
    • Does Aprea Therapeutics, Inc. pay dividends?
    • What sector is Aprea Therapeutics, Inc. in?
    • What industry is Aprea Therapeutics, Inc. in?
    • What country is Aprea Therapeutics, Inc. based in?
    • When did Aprea Therapeutics, Inc. go public?
    • Is Aprea Therapeutics, Inc. in the S&P 500?
    • Is Aprea Therapeutics, Inc. in the NASDAQ 100?
    • Is Aprea Therapeutics, Inc. in the Dow Jones?
    • When was Aprea Therapeutics, Inc.'s last earnings report?
    • When does Aprea Therapeutics, Inc. report earnings?

    What is the ticker symbol for Aprea Therapeutics, Inc.?

    The ticker symbol for Aprea Therapeutics, Inc. is NASDAQ:APRE

    Does Aprea Therapeutics, Inc. pay dividends?

    No, Aprea Therapeutics, Inc. does not pay dividends

    What sector is Aprea Therapeutics, Inc. in?

    Aprea Therapeutics, Inc. is in the Healthcare sector

    What industry is Aprea Therapeutics, Inc. in?

    Aprea Therapeutics, Inc. is in the Biotechnology industry

    What country is Aprea Therapeutics, Inc. based in?

    Aprea Therapeutics, Inc. is headquartered in United States

    When did Aprea Therapeutics, Inc. go public?

    Aprea Therapeutics, Inc.'s initial public offering (IPO) was on October 3, 2019

    Is Aprea Therapeutics, Inc. in the S&P 500?

    No, Aprea Therapeutics, Inc. is not included in the S&P 500 index

    Is Aprea Therapeutics, Inc. in the NASDAQ 100?

    No, Aprea Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Aprea Therapeutics, Inc. in the Dow Jones?

    No, Aprea Therapeutics, Inc. is not included in the Dow Jones index

    When was Aprea Therapeutics, Inc.'s last earnings report?

    Aprea Therapeutics, Inc.'s most recent earnings report was on August 12, 2025

    When does Aprea Therapeutics, Inc. report earnings?

    The next expected earnings date for Aprea Therapeutics, Inc. is November 7, 2025
    On this page